202 related articles for article (PubMed ID: 33178341)
1. Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.
Huang K; Gao N; Bian D; Zhai Q; Yang P; Zhang Y
Exp Ther Med; 2020 Dec; 20(6):243. PubMed ID: 33178341
[TBL] [Abstract][Full Text] [Related]
2. Relationship between BRAF V600E gene mutation and the clinical and pathologic characteristics of papillary thyroid microcarcinoma.
Ji W; Xie H; Wei B; Shen H; Liu A; Gao Y; Wang L
Int J Clin Exp Pathol; 2019; 12(9):3492-3499. PubMed ID: 31934195
[TBL] [Abstract][Full Text] [Related]
3. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma.
Zhou C; Li J; Wang Y; Xue S; Zhang Y
Oncol Lett; 2019 Jan; 17(1):183-194. PubMed ID: 30655754
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
Dong Y; Wang D; Luo Y; Chen L; Bai H; Shen Y; Zhang Y; Chen X; Su X; Zhao J; Liu H; Lu J; Yao Z; Zhao Y; He C; Li X
Oncol Lett; 2021 Mar; 21(3):188. PubMed ID: 33574927
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
6. Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.
Lu ZZ; Zhang Y; Wei SF; Li DS; Zhu QH; Sun SJ; Li M; Li LI
Mol Clin Oncol; 2015 May; 3(3):672-676. PubMed ID: 26137285
[TBL] [Abstract][Full Text] [Related]
7. Younger Than 55 Years Old and
Lai Y; Gu Y; Yu M; Deng J
Int J Gen Med; 2023; 16():1403-1414. PubMed ID: 37155469
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the BRAF(v600E) gene mutation and factors influencing the prognosis of papillary thyroid microcarcinoma.
Sun Y; Shi C; Shi T; Yu J; Li Z
Int J Clin Exp Med; 2015; 8(12):22525-8. PubMed ID: 26885238
[TBL] [Abstract][Full Text] [Related]
9. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract][Full Text] [Related]
10. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients.
Zheng X; Peng C; Gao M; Zhi J; Hou X; Zhao J; Wei X; Chi J; Li D; Qian B
Cancer Biol Med; 2019 Feb; 16(1):121-130. PubMed ID: 31119052
[TBL] [Abstract][Full Text] [Related]
12. Association of BRAF
Attia AS; Hussein M; Issa PP; Elnahla A; Farhoud A; Magazine BM; Youssef MR; Aboueisha M; Shama M; Toraih E; Kandil E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555268
[TBL] [Abstract][Full Text] [Related]
13. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
15. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Zhu D; Wu X; Zhang L; Chen Z
Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946
[TBL] [Abstract][Full Text] [Related]
17. Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
Xiang Y; Xu Y; Bhandari A; Sindan N; Hirachan S; Yang Q; Guo G; Shen Y
Am J Transl Res; 2021; 13(6):6108-6116. PubMed ID: 34306349
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF
Zhang Y; Luo YK; Zhang Y; Zhang MB; Guang Y; Xie F; Jiang B; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):517-523. PubMed ID: 31484615
[TBL] [Abstract][Full Text] [Related]
19. A multivariable model of BRAF
Chen BD; Zhang Z; Wang KK; Shang MY; Zhao SS; Ding WB; Du R; Yu Z; Xu XM
Cancer Manag Res; 2019; 11():7211-7217. PubMed ID: 31440100
[No Abstract] [Full Text] [Related]
20. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
